[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1013598A1 - 1-(5- Isoquinolinesulfonyl) homopipe razine hydrochloride hydrates - Google Patents

1-(5- Isoquinolinesulfonyl) homopipe razine hydrochloride hydrates

Info

Publication number
HK1013598A1
HK1013598A1 HK98112655A HK98112655A HK1013598A1 HK 1013598 A1 HK1013598 A1 HK 1013598A1 HK 98112655 A HK98112655 A HK 98112655A HK 98112655 A HK98112655 A HK 98112655A HK 1013598 A1 HK1013598 A1 HK 1013598A1
Authority
HK
Hong Kong
Prior art keywords
homopipe
isoquinolinesulfonyl
hydrochloride hydrates
razine
razine hydrochloride
Prior art date
Application number
HK98112655A
Other languages
English (en)
Inventor
Hiromu Kawakubo
Masaru Ohno
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Publication of HK1013598A1 publication Critical patent/HK1013598A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK98112655A 1995-07-03 1998-12-02 1-(5- Isoquinolinesulfonyl) homopipe razine hydrochloride hydrates HK1013598A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16746095 1995-07-03
PCT/JP1996/001698 WO1997002260A1 (fr) 1995-07-03 1996-06-19 Hydrochlorates de 1-(5-isoquinoleine sulfonyl)homopiperazine

Publications (1)

Publication Number Publication Date
HK1013598A1 true HK1013598A1 (en) 1999-09-03

Family

ID=15850096

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98112655A HK1013598A1 (en) 1995-07-03 1998-12-02 1-(5- Isoquinolinesulfonyl) homopipe razine hydrochloride hydrates

Country Status (8)

Country Link
US (1) US5942505A (zh)
EP (1) EP0870767B1 (zh)
KR (1) KR100236853B1 (zh)
CN (1) CN1080721C (zh)
DE (1) DE69606721T2 (zh)
ES (1) ES2142065T3 (zh)
HK (1) HK1013598A1 (zh)
WO (1) WO1997002260A1 (zh)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5140031A (en) * 1989-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Pyranyl cyanoguanidine derivatives
WO2000009133A1 (en) * 1998-08-10 2000-02-24 Asahi Kasei Kogyo Kabushiki Kaisha Sustained release oral preparations of fasudil hydrochloride
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
SE0203092D0 (en) * 2002-10-18 2002-10-18 Astrazeneca Ab Method for the synthesis of a benzimidazole compound
US20040266755A1 (en) * 2003-05-29 2004-12-30 Schering Aktiengesellschaft Prodrugs of 1-(1-hydroxy-5-isoquinolinesulfonyl) homopiperazine
WO2005073218A1 (ja) * 2004-01-29 2005-08-11 Asahi Kasei Pharma Corporation バイパス術に伴う血管攣縮治療剤
CA2559630C (en) 2004-03-16 2012-04-17 Asahi Kasei Pharma Corporation Fasudil-containing preparation and method of improving stability thereof
MY139797A (en) * 2004-11-29 2009-10-30 Kowa Co (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1, 4-homopiperazine hydrochloride dihydrate
EP2111863B1 (en) 2005-10-26 2012-03-28 Asahi Kasei Pharma Corporation Fasudil in combination with bosentan for the treament of pulmonary arterial hypertension
AU2007238541A1 (en) * 2006-01-27 2007-10-25 Translational Genomics Research Institute Genes affecting human memory performance
CN101092413B (zh) * 2006-06-23 2011-05-18 山东轩竹医药科技有限公司 法舒地尔的药用盐的水合物
EP2061314A4 (en) * 2006-08-10 2010-08-04 Translational Genomics Res Inst COMPOUNDS FOR IMPROVING LEARNING AND MEMORY
CN102002036B (zh) * 2009-08-31 2013-01-30 秦引林 一种法舒地尔的精制方法
CN102020635B (zh) * 2009-09-10 2013-04-17 河北凯盛医药科技有限公司 一种盐酸法舒地尔半水合物的制备方法
EP2332917B1 (en) 2009-11-11 2012-08-01 Sygnis Bioscience GmbH & Co. KG Compounds for PIM kinase inhibition and for treating malignancy
CN101985444B (zh) * 2010-08-20 2013-04-24 天津红日药业股份有限公司 盐酸法舒地尔的v晶型及其制备方法和用途
CN101962379B (zh) * 2010-09-28 2013-02-27 山西普德药业股份有限公司 一种磺酰基异喹啉衍生物的精制方法
CN102020636A (zh) * 2010-11-25 2011-04-20 江苏万邦生化医药股份有限公司 盐酸法舒地尔的合成及提纯方法
CN102060845B (zh) * 2010-12-28 2013-07-03 天津红日药业股份有限公司 一种法舒地尔的晶型ⅲ及其制备方法和用途
CN102229601B (zh) * 2011-05-12 2013-07-03 天津市汉康医药生物技术有限公司 六氢-1-(5-异喹啉磺酰基)-1(h)-1,4-二氮杂卓盐酸盐无定形化合物
CN102225929B (zh) * 2011-05-12 2014-07-16 天津市汉康医药生物技术有限公司 一种稳定的盐酸法舒地尔水合物化合物
EP2825175B1 (en) 2012-03-12 2017-07-26 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Rho kinase inhibitors for use in treating amyotrophic lateral sclerosis
US8715764B2 (en) 2012-06-21 2014-05-06 Choco Finesse LLC Eutectic mixtures of esterified propoxylated glycerols with digestible fats
CN104327052A (zh) * 2014-10-20 2015-02-04 郑州四环医药用品有限公司 一种高纯度盐酸法舒地尔的制备方法
CN104945381B (zh) * 2015-06-24 2019-05-03 山东罗欣药业集团股份有限公司 一种盐酸法舒地尔化合物、其制备方法及其药物组合物
WO2019084293A1 (en) 2017-10-25 2019-05-02 Arizona Board Of Regents On Behalf Of The University Of Arizona COMPOSITIONS AND METHODS FOR ADMINISTERING PHARMACEUTICAL AGENTS
PL3901141T3 (pl) 2018-12-17 2024-05-27 D. Western Therapeutics Institute, Inc. Nowa postać sulfonamidu izochinoliny
CN109776497A (zh) * 2019-03-07 2019-05-21 山东新华制药股份有限公司 一种盐酸法舒地尔半水合物的制备方法
WO2020193802A1 (en) 2019-03-28 2020-10-01 Fundación De La Comunidad Valenciana Centro De Investigación Príncipe Felipe Polymeric conjugates and uses thereof
CN113968841B (zh) * 2020-07-23 2024-05-14 合肥久诺医药科技有限公司 一种盐酸法舒地尔半水合物的制备方法
WO2023076812A1 (en) 2021-10-30 2023-05-04 Aneuryst, Inc. Treatments for disturbed cerebral homeostasis
CN118922193A (zh) 2022-02-17 2024-11-08 悟而喜制药公司 具有离子交换树脂的法舒地尔口服制剂
US20230330100A1 (en) 2022-02-17 2023-10-19 Woolsey Pharmaceuticals, Inc. Taste-masking oral formulations of fasudil

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678783B1 (en) * 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
JPS61152658A (ja) * 1984-12-27 1986-07-11 Asahi Chem Ind Co Ltd 置換されたイソキノリンスルホンアミド誘導体
JPS6293643A (ja) * 1985-10-19 1987-04-30 Fuji Photo Film Co Ltd 核酸の塩基配列決定のための信号処理方法
JP2720348B2 (ja) * 1989-03-30 1998-03-04 旭化成工業株式会社 脳細胞機能障害改善剤
JPH04278094A (ja) * 1991-03-07 1992-10-02 Asahi Chem Ind Co Ltd １−ヒドロキシ−イソキノリンスルホンアミド誘導体の製造方法
JPH05569A (ja) * 1991-06-25 1993-01-08 Kanzaki Paper Mfg Co Ltd 感熱記録体
JPH0680569A (ja) * 1992-09-03 1994-03-22 Asahi Chem Ind Co Ltd 血小板凝集阻害剤
JP3464012B2 (ja) * 1993-04-05 2003-11-05 旭化成株式会社 精神症候治療剤
JPH0741424A (ja) * 1993-07-28 1995-02-10 Asahi Chem Ind Co Ltd 抗炎症剤

Also Published As

Publication number Publication date
WO1997002260A1 (fr) 1997-01-23
US5942505A (en) 1999-08-24
ES2142065T3 (es) 2000-04-01
CN1183782A (zh) 1998-06-03
KR100236853B1 (ko) 2000-02-01
CN1080721C (zh) 2002-03-13
DE69606721T2 (de) 2000-06-21
EP0870767A4 (zh) 1998-10-14
EP0870767B1 (en) 2000-02-16
KR19990008278A (ko) 1999-01-25
EP0870767A1 (en) 1998-10-14
DE69606721D1 (de) 2000-03-23

Similar Documents

Publication Publication Date Title
HK1013598A1 (en) 1-(5- Isoquinolinesulfonyl) homopipe razine hydrochloride hydrates
EG24195A (en) Heterocyclic compounds
PL331795A1 (en) Heterocyclic metaloprotease inhibitors
EP0835109A4 (en) PYRIDINONE-BASED THROMBIN INHIBITORS
PL327406A1 (en) 1-(1,2-disubstituted-piperidinyl)-4-substituted derivatives of piperazine
GB9512697D0 (en) Heterocyclic compounds
GB9518552D0 (en) New heterocyclic compounds
IL129122A0 (en) N-substituted azaheterocyclic compounds
AP9700968A0 (en) Apolipoprotein-B synthesis inhibitors
GB9504361D0 (en) Heterocyclic compounds
ZA959084B (en) Apolipoprotein-b synthesis inhibitors
IL129121A0 (en) N-substituted azaheterocyclic compounds
PL311997A1 (en) Aqualene synthetase inhibitors
GB9505865D0 (en) Hydrate Inhibitors
HU9503466D0 (en) New heterocyclic amides
ZA962734B (en) Heterocyclic compounds
GB9404942D0 (en) Heterocyclic compound
IL126564A0 (en) 1-(1-Oxoindan-2-yl) imidazole-2-carboxylate derivatives
HUT71675A (en) Guanidyl-substituted heterocyclic thrombin inhibitors
GB9512339D0 (en) New heterocyclic compounds
GB9521102D0 (en) New Heterocyclic compounds
GB9425971D0 (en) Heterocyclic arylacetamides
GB9511507D0 (en) Heterocyclic compounds
ZA962738B (en) Heterocyclic compounds
GB9504383D0 (en) Heterocyclic compounds

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150619